Clinical Trial of OMKK03 for De Novo Coronary Artery Lesions and Coronary Artery In-Stent Restenosis (Clinical Trial of OMKK03 for De Novo Coronary Artery Lesions and Coronary Artery In-Stent Restenosis)

未提供0 个研究点目标入组 282 人开始时间: 待定

适应症

试验速览

暂无简介。

•The subject must be 18 years of age or older.
•The subject must understand the requirements of this clinical trial and the trial procedures, and must provide written informed consent for participation in this clinical trial prior to undergoing any examinations or procedures related to the trial.
•The subject must be indicated for percutaneous coronary intervention (PCI).

•Patients with acute myocardial infarction within 72 hours prior to the study procedure.
•Patients with cardiogenic shock, unstable hemodynamics requiring inotropic agents or mechanical circulatory support, refractory ventricular arrhythmias, or progressive refractory angina.
•Patients with severe left ventricular dysfunction with a left ventricular ejection fraction of less than 30%.

发起方

未提供